IGI, 10% with rHuPH20

· Baxalta (now part of Shire)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IGI, 10% with rHuPH20, covering 2017-04-24 to 2017-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD [Phase 2, Phase 3]